Skip to main content

Table 1 Antibodies used and immunohistchemical result.

From: Stromal micropapillary pattern predominant lung adenocarcinoma - a report of two cases

Antibody Clone Dilution Source Stroma around the micropapillary clusters Tumor cells
       in SMP outside SMP
     Case1 Case2 Case1 Case2 Case1 Case2
MUC1 Ma695 1:100 Novocastra 0 0 2+ 2+ 1+ 2+
EMA E29 Pre-diluted Cell Marque 0 0 2+ 2+ 2+ 2+
E-cadherin NCH38D 1:100 DakoCytomation 0 0 2+ 2+ 2+ 2+
CK AE1/AE3 Pre-diluted Nichirei 0 0 2+ 2+ 2+ 2+
TTF-1 8G7G3/1 1:100 DakoCytomation 0 0 1+ 2+ 2+ 2+
SP-A PE10 1:100 Dako 0 0 1+ 0 2+ 2+
D2-40 D2-40 Pre-diluted Nichirei 0 0 0 0 0 0
CD34 Nu-4A1 Pre-diluted Nichirei 0 0 0 0 0 0
FactorVIII polyclonal 1:200 DAKO 0 0 0 0 0 0
  1. EMA, epithelial membrane antigen; CK, cytokeratin; TTF-1, thyroid transcription factor-1; SP-A, surfactant protein A.
  2. Novocastra, Newcastle Upon Tyne, UK; Cell Marque, Hot springs, AR, USA; DakoCytomation, Carpinteria, CA, USA; Dako, Kyoto, Japan; Nichirei, Tokyo, Japan; DAKO, Glostrup, Denmark.
  3. 0, no positive cells; 1+, positive tumor cells less than 10%; 2+, 10% or more.